WVE News and Press, Wave Life Sciences Ltd. From 12/13/22

Wave receives upfront payment of $170 million in cash and equity, also eligible to receive milestone payments and royalties Collaboration brings together Wave’s PRISM™ oligonucleotide platform and GSK’s expertise in genetics and genomics GSK to advance up ...

Wave Life Sciences Ltd. (WVE) Q3 2022 Earnings Conference Call November 10, 2022 08:30 AM ET Company Participants Kate Rausch - Head, Investor Relations Paul Bolno - President & Chief Executive Officer Anne-Marie Li-Kwai-Cheung - Chief Development Officer ...

The following slide deck was published by Wave Life Sciences Ltd. in conjunction with their 2022 Q3 earnings call. For further details see: Wave Life Sciences Ltd. 2022 Q3 - Results - Earnings Call Presentation

Wave Life Sciences press release ( NASDAQ: WVE ): Q3 GAAP EPS of -$0.42 beats by $0.08 . Revenue of $0.29M (-99.2% Y/Y) misses by $5.11M . As of September 30, 2022, Wave had $122.0 million in cash, cash equivalents and short-term investments. ...

Announced positive update in third quarter from SELECT-HD trial in HD; single doses of WVE-003 appeared generally safe and well-tolerated and suggested allele-selective reduction of mHTT protein in CSF Multidosing underway in Phase 1b/2a trial of WVE-N531 in boys with DMD amenab...

Wave Life Sciences ( NASDAQ: WVE ) is scheduled to announce Q3 earnings results on Thursday, November 10th, before market open. The consensus EPS Estimate is -$0.50 (-316.7% Y/Y) and the consensus Revenue Estimate is $5.4M (-85.2% Y/Y). Over the last 1 year, WVE has ...

CAMBRIDGE, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Exec...

Summary Two new Breakout Stocks for Week 45 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now down to +109.9% YTD. This week one stock gained 10% in less than a week with EPM +10.6% and GWH +7.6% while ENVX missed Q3 earnings for a ...

CAMBRIDGE, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and confe...

Summary Two new Breakout Stocks for Week 44 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now up to +112.8% YTD. This week two stocks gained 10% in less than a week with MAG +11.5% and WTTR +10% while another high frequency breakout...